These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27336888)

  • 21. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study.
    Dahan M; O'Donnell S; Hebert J; Gonzales M; Lee B; Chandran AU; Woolsey S; Escoredo S; Chinnery H; Quach C
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1446-1452. PubMed ID: 27609629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nurse-driven quality improvement interventions to reduce hospital-acquired infection in the NICU.
    Ceballos K; Waterman K; Hulett T; Makic MB
    Adv Neonatal Care; 2013 Jun; 13(3):154-63; quiz 164-5. PubMed ID: 23722485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Results of a National Intervention to Prevent Central Line-Associated Bloodstream Infection: A Pre-Post Observational Study.
    Patel PK; Greene MT; Jones K; Rolle AJ; Ratz D; Snyder A; Saint S; Chopra V
    Ann Intern Med; 2019 Oct; 171(7_Suppl):S23-S29. PubMed ID: 31569230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreasing Central Line-Associated Bloodstream Infections Acquired in the Home Setting Among Pediatric Oncology Patients [Formula: see text].
    Altounji D; McClanahan R; O'Brien R; Murray P
    J Pediatr Oncol Nurs; 2020; 37(3):204-211. PubMed ID: 32102609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central venous catheter-associated bloodstream infections in children diagnosed with intestinal failure in Southern Israel.
    Nassar R; Hazan G; Leibovitz E; Ling G; Lazar I; Khalaila A; Fruchtman Y; Yerushalmi B
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):517-525. PubMed ID: 31768705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel risk factors for central-line associated bloodstream infections in critically ill children.
    Woods-Hill CZ; Srinivasan L; Schriver E; Haj-Hassan T; Bezpalko O; Sammons JS
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):67-72. PubMed ID: 31685049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central-Line-Associated Bloodstream Infections in Québec Intensive Care Units: Results from the Provincial Healthcare-Associated Infections Surveillance Program (SPIN).
    Li L; Fortin E; Tremblay C; Ngenda-Muadi M; Quach C;
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1186-94. PubMed ID: 27430754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes associated with peripherally inserted central catheters in hospitalised children: a retrospective 7-year single-centre experience.
    Badheka A; Bloxham J; Schmitz A; Freyenberger B; Wang T; Rampa S; Turi J; Allareddy V; Auslender M; Allareddy V
    BMJ Open; 2019 Aug; 9(8):e026031. PubMed ID: 31444177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair of damaged central venous catheters is safe and doubles catheter survival: a home parenteral nutrition patient cohort study.
    Wouters Y; Vissers RK; Groenewoud H; Kievit W; Wanten GJA
    Clin Nutr; 2019 Aug; 38(4):1692-1699. PubMed ID: 30146167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymptomatic central line-associated bloodstream infections in children implanted with long term indwelling central venous catheters in a teaching hospital, Sri Lanka.
    Jayaweera JAAS; Sivakumar D
    BMC Infect Dis; 2020 Jun; 20(1):457. PubMed ID: 32600427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLUG Bug: Quality Improvement With Orchestrated Testing Leads to NICU CLABSI Reduction.
    Piazza AJ; Brozanski B; Provost L; Grover TR; Chuo J; Smith JR; Mingrone T; Moran S; Morelli L; Zaniletti I; Pallotto EK
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26702032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
    Rogers AE; Eisenman KM; Dolan SA; Belderson KM; Zauche JR; Tong S; Gralla J; Hilden JM; Wang M; Maloney KW; Dominguez SR
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27616655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of an international nosocomial infection control consortium multidimensional approach on central line-associated bloodstream infection rates in adult intensive care units in eight cities in India.
    Jaggi N; Rodrigues C; Rosenthal VD; Todi SK; Shah S; Saini N; Dwivedy A; Udwadia FE; Mehta P; Chakravarthy M; Singh S; Sahu S; Govil D; Hegd A; Kapadia F; Bhakta A; Bhattacharyya M; Singhal T; Naik R; Kothari V; Gupta A; Shetty S; Binu S; Pinto P; Poojary A; Koppikar G; Bhandarkar L; Jadhav S; Chavan N; Bahirune S; Durgad S; Nataraj G; Surase P; Gokul BN; Sukanya R; Pushparaj L; Radhakrishnan K
    Int J Infect Dis; 2013 Dec; 17(12):e1218-24. PubMed ID: 24084244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact and cost-effectiveness of split-septum and single-use prefilled flushing device vs 3-way stopcock on central line-associated bloodstream infection rates in India: a randomized clinical trial conducted by the International Nosocomial Infection Control Consortium (INICC).
    Rosenthal VD; Udwadia FE; Kumar S; Poojary A; Sankar R; Orellano PW; Durgad S; Thulasiraman M; Bahirune S; Kumbhar S; Patil P
    Am J Infect Control; 2015 Oct; 43(10):1040-5. PubMed ID: 26164769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R; Gordon SM; Fatica C; Fraser TG
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multitiered strategy of simulation training, kit consolidation, and electronic documentation is associated with a reduction in central line-associated bloodstream infections.
    Allen GB; Miller V; Nicholas C; Hess S; Cordes MK; Fortune JB; Blondin J; Ashikaga T; Ricci M
    Am J Infect Control; 2014 Jun; 42(6):643-8. PubMed ID: 24837115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denominator doesn't matter: standardizing healthcare-associated infection rates by bed days or device days.
    Horstman MJ; Li YF; Almenoff PL; Freyberg RW; Trautner BW
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):710-6. PubMed ID: 25782986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
    Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.